Second Amendment to License AgreementLicense Agreement • August 12th, 2024 • Apogee Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Second Amendment to License Agreement is dated February 26, 2024 (“Second Amendment”) and is entered into between Apogee Therapeutics, Inc., (“Licensee”) and MIL 6T, LLC (“Licensor”).
License AgreementLicense Agreement • August 12th, 2024 • Apogee Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This License Agreement, made and entered into as of November 22, 2023 (“Agreement”), is by and between Apogee Therapeutics, Inc., a Delaware corporation, having a place of business located at 221 Crescent Street, Building 17, Suite 102b, Waltham, MA 02453 (“Licensee”) and MIL 6T, LLC, a Delaware limited liability company having a place of business located at 6 Tide Street, Boston, MA 02210 (“SmartLabs”).
Third Amendment to License AgreementLicense Agreement • August 12th, 2024 • Apogee Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Third Amendment to License Agreement is dated June 10, 2024 (“Third Amendment”) and is entered into between Apogee Therapeutics, Inc., (“Licensee”) and MIL 6T, LLC (“Licensor”).
First Amendment to License AgreementLicense Agreement • August 12th, 2024 • Apogee Therapeutics, Inc. • Biological products, (no disgnostic substances)
This First Amendment to License Agreement is dated December 4, 2023 (“First Amendment”) and is entered into between Apogee Therapeutics, Inc., (“Licensee”) and MIL 6T, LLC (“Licensor”).
